Inventor
ROTHER RUSSELL P
US34 patents
⚠️ This page may combine multiple inventors who share the name “ROTHER RUSSELL P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALEXION PHARMA INC
26 patentsUS6355245B1Mar 12, 2002
C5-specific antibodies for the treatment of inflammatory diseases
ALEXION PHARMA INC465 citations97
US9732149B2Aug 15, 2017
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
ALEXION PHARMA INC15 citations92
US9725504B2Aug 8, 2017
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
ALEXION PHARMA INC14 citations92
US9718880B2Aug 1, 2017
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
ALEXION PHARMA INC17 citations92
US9221901B2Dec 29, 2015
Methods of treating complement-associated disorders with anti-C5a antibodies
ALEXION PHARMA INC11 citations92
US5871997AFeb 16, 1999
Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes
ALEXION PHARMA INC19 citations90
US10703809B1Jul 7, 2020
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
ALEXION PHARMA INC3 citations84
US10590189B2Mar 17, 2020
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
ALEXION PHARMA INC7 citations84
US9469690B2Oct 18, 2016
Methods of treating complement-associated disorders with anti-C5a antibodies
ALEXION PHARMA INC4 citations84
US9434784B1Sep 6, 2016
Nucleic acids encodng anti-C5A antibodies
ALEXION PHARMA INC4 citations84
US9371378B1Jun 21, 2016
Anti-C5a antibodies
ALEXION PHARMA INC7 citations84
US9309310B2Apr 12, 2016
Nucleic acids encoding anti-C5a antibodies
ALEXION PHARMA INC7 citations84
US9771418B2Sep 26, 2017
Methods for treating complement-associated disorders
ALEXION PHARMA INC8 citations83
US11807678B2Nov 7, 2023
Methods and compositions for treating complement-associated disorders
ALEXION PHARMA INC2 citations73
US10450370B2Oct 22, 2019
Anti-C5a antibodies
ALEXION PHARMA INC2 citations73
US9963503B2May 8, 2018
Methods of producing anti-C5a antibodies
ALEXION PHARMA INC2 citations73
US9862767B2Jan 9, 2018
Therapeutic methods using anti-CD200 antibodies
ALEXION PHARMA INC3 citations73
US7399594B2Jul 15, 2008
Hybrid antibodies
ALEXION PHARMA INC7 citations73
US5891645AApr 6, 1999
Porcine E-selectin
ALEXION PHARMA INC5 citations73
USRE46323EFeb 28, 2017
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
ALEXION PHARMA INC3 citations72
US5562904AOct 8, 1996
Retroviral transduction of cells using soluble complement inhibitors
ALEXION PHARMA INC14 citations72
US11407821B2Aug 9, 2022
Anti-C5A antibodies
ALEXION PHARMA INC0 citations62
US7927817B2Apr 19, 2011
Hybrid antibodies
ALEXION PHARMA INC1 citations62
US11112402B2Sep 7, 2021
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
ALEXION PHARMA INC0 citations55
US6040428AMar 21, 2000
Porcine E-selectin
ALEXION PHARMA INC1 citations51
US10126293B2Nov 13, 2018
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
ALEXION PHARMA INC1 citations44
ROTHER RUSSELL P
7 patentsUS9085623B2Jul 21, 2015
Therapeutic methods using anti-CD200 antibodies
ROTHER RUSSELL P50 citations97
US9011852B2Apr 21, 2015
Anti-C5a antibodies
ROTHER RUSSELL P25 citations92
US9447176B2Sep 20, 2016
Methods and compositions for treating complement-associated disorders
ROTHER RUSSELL P21 citations91
US8637014B2Jan 28, 2014
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
ROTHER RUSSELL P7 citations83
US8252285B2Aug 28, 2012
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
ROTHER RUSSELL P8 citations83
US8282924B2Oct 9, 2012
Hybrid antibodies
ROTHER RUSSELL P5 citations72
US8067167B2Nov 29, 2011
Hybrid antibodies
ROTHER RUSSELL P1 citations61